Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients - Concepedia

Concepedia

Publication | Open Access

Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients

DOI Full Paper Access

124

Citations

38

References

2008

Year

Ioannis Boukovinas, Chara Papadaki, Pedro Méndez, Miquel Tarón, Dimitris Mavroudis, Anastasios Koutsopoulos, María Sanchez-Ronco, José Javier Sánchez, Maria Trypaki, Eustathios Staphopoulos,

Abstract

The mRNA expression of BRCA1, RRM1 and RRM2 is potentially a useful tool for selecting NSCLC patients for individualized chemotherapy and warrants further investigation in prospective studies.

References

	Year	Citations

Page 1